Suppr超能文献

心力衰竭和慢性肾脏病病史与 COVID-19 大流行前三个波期间及瑞典流感暴发期间全因死亡风险的比较:基于登记的回顾性病例对照研究。

History of heart failure and chronic kidney disease and risk of all-cause death after COVID-19 during the first three waves of the pandemic in comparison with influenza outbreaks in Sweden: a registry-based, retrospective, case-control study.

机构信息

Cardiology Unit, Department of Medicine, Solna, Karolinska Institute, Stockholm, Sweden

Department of Research and Development, Region Kronoberg, Vaxjo, Sweden.

出版信息

BMJ Open. 2023 Apr 28;13(4):e069037. doi: 10.1136/bmjopen-2022-069037.

Abstract

OBJECTIVES

To explore how cardiorenal disease (CRD; heart failure and/or chronic kidney disease) impacted mortality in men and women hospitalised for COVID-19 during the first three waves of the pandemic in Sweden in comparison to previous influenza outbreaks.

DESIGN

A registry-based, retrospective, case-control study.

SETTING

Hospital care in Sweden.

PARTICIPANTS

All patients in Sweden with a main hospital diagnosis of COVID-19 (January 2020-September 2021) or influenza (January 2015-December 2019) with previous CRD were identified in registries and compared with a reference group free from CRD but with COVID-19 or influenza.

PRIMARY OUTCOME MEASURE

Associated risk of all-cause death during the first year was analysed using adjusted Cox proportional hazards models.

RESULTS

In COVID-19 patients with and without prior history of CRD (n=44 866), mean age was 79.8 years (SD 11.8) and 43% were women. In influenza patients (n=8897), mean age was 80.6 years (SD 11.5) and 45% were women. COVID-19 versus influenza was associated with higher mortality risk during the first two COVID-19 waves (HR 1.53; 95% CI 1.45 to 1.62, p<0.001 and HR 1.52; 95% CI 1.44 to 1.61, p<0.001), but not in the third wave (HR 1.07; 95% CI 0.99 to 1.14, p=0.072). CRD was an independent risk factor for all-cause death after COVID-19 in men and women (men: 1.37; 95% CI 1.31 to 1.44, p<0.001; women: 1.46; 95% CI 1.38 to 1.54, p<0.001). At ages <70 years, women with CRD had a similar mortality rate to men with CRD, while at ages ≥70 years, the mortality rate was higher in men.

CONCLUSIONS

Outcome after COVID-19 is worse if CRD is present. In women at ages <70 years, the presence of CRD attenuates the protective effect of female sex. COVID-19 was associated with higher mortality risk than influenza during the first two pandemic waves.

摘要

目的

探讨在瑞典 COVID-19 大流行的前三个波次期间,与既往流感暴发相比,合并或不合并心肾疾病(心衰和/或慢性肾病)的 COVID-19 住院患者的死亡率。

设计

基于登记的回顾性病例对照研究。

地点

瑞典医院。

参与者

所有在瑞典因 COVID-19(2020 年 1 月至 2021 年 9 月)或流感(2015 年 1 月至 2019 年 12 月)住院且有既往心肾疾病主要诊断的患者均在登记处确定,并与无心肾疾病但有 COVID-19 或流感的参考组进行比较。

主要结局指标

采用校正后的 Cox 比例风险模型分析第一年全因死亡的风险比。

结果

在有或无既往心肾疾病史的 COVID-19 患者(n=44866)中,平均年龄为 79.8 岁(SD 11.8),43%为女性。在流感患者(n=8897)中,平均年龄为 80.6 岁(SD 11.5),45%为女性。与流感相比,前两波 COVID-19 期间 COVID-19 与更高的死亡率相关(HR 1.53;95%CI 1.45 至 1.62,p<0.001 和 HR 1.52;95%CI 1.44 至 1.61,p<0.001),但在第三波中无相关性(HR 1.07;95%CI 0.99 至 1.14,p=0.072)。在心肾疾病患者中,无论男性还是女性,COVID-19 后全因死亡都是独立的危险因素(男性:1.37;95%CI 1.31 至 1.44,p<0.001;女性:1.46;95%CI 1.38 至 1.54,p<0.001)。在年龄<70 岁的女性中,CRD 患者的死亡率与男性相似,而在年龄≥70 岁的女性中,男性的死亡率更高。

结论

如果存在心肾疾病,COVID-19 后的结局更差。在年龄<70 岁的女性中,CRD 的存在削弱了女性性别带来的保护作用。在头两个大流行波次期间,COVID-19 导致的死亡率高于流感。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fd50/10875479/3c584db8cade/bmjopen-2022-069037f01.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验